3rd CUHK Sarcoma Masterclass

Malaysia
Search
Sign In

Oncology

Oncology

Home News Diseases Conferences Special Reports Multimedia

3rd CUHK Sarcoma Masterclass

RT plus immunotherapy holds potential for sarcoma treatment

Natalia Reoutova, 20191119000000

Advances in radiotherapy (RT) and immuno-oncology are poised to benefit sarcoma patients, many of whom do not respond to chemotherapy.

Denosumab of benefit in selected patients with giant cell tumour of bone

Christina Lau, 20191014043654

Denosumab can be of benefit to patients with unresectable giant cell tumour of bone (GCTB) and those who are likely to experience significant morbidity after surgical resection of GCTB.

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!

Role of tumour treating fields in the management of glioblastoma

Dr. Jay Zhu, Dr. Lai Fung Li, Prof. Chae-Yong Kim, 27 Nov 2019

The current standard of care for glioblastoma multiforme (GBM), an aggressive primary brain tumour with a rapid disease course, consists of maximum safe surgical resection followed by radiotherapy with concomitant temozolomide (TMZ) chemotherapy and subsequent TMZ maintenance. At the 16th Annual Meeting of the Asian Society of Neuro-Oncology (ASNO) in Taipei, Taiwan, experts reviewed the evidence and shared their clinical experience on the use of tumour treating fields (TTFields), a novel treatment modality for GBM.